Download tear sheets to share with patients. These patient-focused resources are produced by ASH in collaboration with patient organizations.
February 2017: Navigating Clinical Trials
Thursday, February 2nd, 2017 | February 2017, Volume 3, Issue 3
A clinical trial is a controlled research study conducted by doctors and medical researchers to improve the care and treatment of people who have hematologic disorders or cancer. Taking part in a clinical trial may be the best treatment choice for some patients. There are trials for patients at every stage of treatment as well […]
December 2016: Women and the Risk of Blood Clots
Tuesday, November 22nd, 2016 | December 2016, Volume 2, Issue 12
Nearly 900,000 people are affected by blood clots each year, leading to approximately 100,000 blood clot-related deaths annually. Dangerous blood clots such as deep-vein thrombosis (DVT) often form in the veins of a person’s arm or leg. If a DVT is left untreated, the clot can break loose and travel to the lungs (pulmonary embolism […]
November 2016: The Pediatric Patient Living With Sickle Cell Disease
Friday, October 28th, 2016 | November 2016, Volume 2, Issue 11
Sickle cell disease (SCD) is the most common genetic disorder in the United States, with about 100,000 American who have the disease and another 2 million who carry the trait. As people live with SCD for years, management of this disease and healthy living are important components of care, particularly for the pediatric population. Read […]
October 2016: Understanding Bone and Blood Marrow Transplants
Monday, October 3rd, 2016 | October 2016, Volume 2, Issue 10
Bone marrow is the soft tissue inside the bones that makes blood-forming cells known as blood stem cells. These grow into red blood cells (carry oxygen throughout the body), white blood cells (help fight infections), or platelets (help control bleeding). Healthy marrow and blood cells are needed to live. When a disease such as cancer […]
August 2016: What Is Acute Myeloid Leukemia?
Monday, August 1st, 2016 | August 2016, Volume 2, Issue 8
Acute myeloid leukemia (AML) is the most common acute leukemia in the United States, comprising 33 percent of all leukemias. The cancer progresses rapidly if not treated, making timely diagnosis an important goal. Recent diagnostic tests and treatment options such as stem cell transplantation are improving the remission and cure rates for some patients with […]